Evidence map›Paper›PMID 30017200›Full record

ArticleBiochemical and biophysical research communications2018

Prototype foamy virus integrase is promiscuous for target choice.

R M Mackler, M A Lopez, M J Osterhage, K E Yoder

Open access · hybridAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Foamy Virus Integrase in Development of Viral Vector for Gene Therapy.Journal of microbiology and biotechnology · 2020
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

R M MacklerDepartment of Cancer Biology and Genetics, Ohio State University College of Medicine, 460 West 12(th)Ave, Columbus, OH, 43210, USA.
M A LopezDepartment of Cancer Biology and Genetics, Ohio State University College of Medicine, 460 West 12(th)Ave, Columbus, OH, 43210, USA.
M J OsterhageDepartment of Cancer Biology and Genetics, Ohio State University College of Medicine, 460 West 12(th)Ave, Columbus, OH, 43210, USA.
K E YoderDepartment of Cancer Biology and Genetics, Ohio State University College of Medicine, 460 West 12(th)Ave, Columbus, OH, 43210, USA. Electronic address: yoder.176@osu.edu.
Cancer Genetics (United States) · USThe Ohio State University · US

Funding

The Mechanics of Retroviral IntegrationR01AI126742 · NIAID · OHIO STATE UNIVERSITY · PI FISHEL, RICHARD, YODER, KRISTINE E · 2017 to 2021
$1.9M
NIAID NIH HHS R01 AI126742
6 · The paper itself

Abstract

Retroviruses have two essential activities: reverse transcription and integration. The viral protein integrase (IN) covalently joins the viral cDNA genome to the host DNA. Prototype foamy virus (PFV) IN has become a model of retroviral intasome structure. However, this retroviral IN has not been well-characterized biochemically. Here we compare PFV IN to previously reported HIV-1 IN activities and discover significant differences. PFV IN is able to utilize the divalent cation calcium during strand transfer while HIV-1 IN is not. HIV-1 IN was shown to completely commit to a target DNA within 1 min, while PFV IN is not fully committed after 60 min. These results suggest that PFV IN is more promiscuous compared to HIV-1 IN in terms of divalent cation and target commitment.

Indexed as

DNA, ViralHIV-1IntegrasesSpumavirusSubstrate SpecificityDNA, ViralIntegrasesDivalent cationEnzymologyIntegrasePrototype foamy virusRetrovirus

Identifiers

PMID30017200
PMCPMC6119477
OpenAlexW2884295234

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.